Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

ANI Pharmaceuticals, Inc. (ANIP)

NGM · Drug Manufacturers - Specialty & Generic

$81.04+2.67 (+3.41%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$1.84B
P/E (TTM)
20.06
EPS
$4.04
Div Yield
52W Range
$62.61–$99.50
Beta
0.43

Company overview

Next earnings: 2026-08-07(10d)

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Peers in Drug Manufacturers - Specialty & Generic

All in industry →

Recent press releases

ANI Pharmaceuticals, Inc. has not issued a press release in this window.

SEC filings

All filings →

ANI Pharmaceuticals, Inc. has not filed an SEC document in this window.

ANI Pharmaceuticals, Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
33,115 sh-94.4%
150,779 sh-74.4%
539,665 sh+727.1%
121,211 sh-69.6%
2,661,712 sh+4.4%
257,773 sh● NEW
1,305,068 sh+2.2%

People at ANI Pharmaceuticals, Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
03/25
$103.0M
NI $15.7M
06/25
$117.2M
NI $8.5M
09/25
$227.8M
NI $26.6M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $1.13
Prior: $0.36
Revenue sparkline